Haemonetics (HAE) stock Forecast for 2022 – 2026

Haemonetics (HAE) stock Forecast for 2022 – 2026

Last update: 05-24-2022, 11:49

Sector: Healthcare

The share price of Haemonetics Corporation (HAE) now

What analysts predict:: $70.17

52-week high/low: $75.34 / $43.5

50/200 Day Moving Average: $56.32 / $58.68

This figure corresponds to the average price over the previous 50/200 days. For Haemonetics stocks, the 50-day moving average is the support level today.

For Haemonetics stocks, the 200-day moving average is the support level today.

Are you interested in Haemonetics Corporation stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Haemonetics stock price in 2022, 2023, 2024, 2025, 2026. How much will one Haemonetics share be worth in 2022 - 2026?

When should I take profit in Haemonetics stock? When should I record a loss on Haemonetics stock? What are analysts' forecasts for Haemonetics stock? What is the future of Haemonetics stock?

We forecast Haemonetics stock performance using neural networks based on historical data on Haemonetics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Haemonetics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026)

The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Haemonetics shares. This happens once a day.




Historical and forecast chart of Haemonetics stock

The chart below shows the historical price of Haemonetics stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Haemonetics stock price can be found in the table below.

Long-term forecasts by years.

Haemonetics daily forecast for a month

Date Target Pes. Opt. Vol., %
May 26 61.98 60.86 63.34 4.08
May 27 62.57 62.02 63.69 2.69
May 28 63.19 62.16 63.97 2.92
May 29 63.35 62.41 64.40 3.18
May 30 62.74 61.42 64.00 4.21
May 31 63.84 62.84 65.30 3.92
Jun 01 63.34 62.09 64.03 3.14
Jun 02 62.62 61.26 63.55 3.74
Jun 03 63.15 62.25 64.28 3.27
Jun 04 61.86 60.86 63.26 3.95
Jun 05 62.04 61.23 63.21 3.23
Jun 06 63.65 62.19 64.61 3.89
Jun 07 64.11 63.72 65.37 2.60
Jun 08 65.07 64.49 66.22 2.69
Jun 09 65.09 64.72 66.34 2.51
Jun 10 64.66 64.06 65.33 1.99
Jun 11 66.40 65.54 67.06 2.32
Jun 12 65.88 65.31 66.68 2.11
Jun 13 65.48 64.84 65.94 1.70
Jun 14 64.72 63.33 66.20 4.53
Jun 15 65.58 64.63 66.40 2.74
Jun 16 64.50 63.88 65.19 2.05
Jun 17 64.15 62.99 64.68 2.69
Jun 18 63.64 62.89 64.47 2.52
Jun 19 62.72 62.25 63.92 2.69
Jun 20 63.38 62.70 64.00 2.08
Jun 21 62.79 61.59 63.59 3.25
Jun 22 62.75 61.62 64.02 3.90
Jun 23 62.77 62.06 63.26 1.94
Jun 24 63.01 62.55 64.23 2.69

Haemonetics Daily Price Targets


Haemonetics Stock Forecast 05-26-2022.

Forecast target price for 05-26-2022: $61.98. Positive dynamics for Haemonetics shares will prevail with possible volatility of 3.916%.

Pessimistic target level: 60.86

Optimistic target level: 63.34


Haemonetics Stock Forecast 05-27-2022.

Forecast target price for 05-27-2022: $62.57. Positive dynamics for Haemonetics shares will prevail with possible volatility of 2.621%.

Pessimistic target level: 62.02

Optimistic target level: 63.69


Haemonetics Stock Forecast 05-28-2022.

Forecast target price for 05-28-2022: $63.19. Positive dynamics for Haemonetics shares will prevail with possible volatility of 2.836%.

Pessimistic target level: 62.16

Optimistic target level: 63.97


Haemonetics Stock Forecast 05-29-2022.

Forecast target price for 05-29-2022: $63.35. Positive dynamics for Haemonetics shares will prevail with possible volatility of 3.081%.

Pessimistic target level: 62.41

Optimistic target level: 64.40


Haemonetics Stock Forecast 05-30-2022.

Forecast target price for 05-30-2022: $62.74. Negative dynamics for Haemonetics shares will prevail with possible volatility of 4.037%.

Pessimistic target level: 61.42

Optimistic target level: 64.00


Haemonetics Stock Forecast 05-31-2022.

Forecast target price for 05-31-2022: $63.84. Positive dynamics for Haemonetics shares will prevail with possible volatility of 3.771%.

Pessimistic target level: 62.84

Optimistic target level: 65.30


HAE (HAE) Monthly Stock Prediction for 2022

Month Target Pes. Opt. Vol., %
Jun. 63.71 60.27 65.50 7.98
Jul. 67.73 64.81 69.83 7.18
Aug. 66.98 63.10 69.86 9.68
Sep. 67.12 65.71 68.79 4.49
Oct. 61.61 59.02 63.83 7.53
Nov. 62.84 59.45 66.74 10.92
Dec. 66.74 62.67 71.68 12.57

Haemonetics forecast for this year


Haemonetics Stock Prediction for Jun 2022

An uptrend is forecast for this month with an optimal target price of $63.7123. Pessimistic: $60.27. Optimistic: $65.50


Haemonetics Stock Prediction for Jul 2022

An uptrend is forecast for this month with an optimal target price of $67.7262. Pessimistic: $64.81. Optimistic: $69.83


Haemonetics Stock Prediction for Aug 2022

An downtrend is forecast for this month with an optimal target price of $66.9812. Pessimistic: $63.10. Optimistic: $69.86


Haemonetics Stock Prediction for Sep 2022

An uptrend is forecast for this month with an optimal target price of $67.1152. Pessimistic: $65.71. Optimistic: $68.79


Haemonetics Stock Prediction for Oct 2022

An downtrend is forecast for this month with an optimal target price of $61.6117. Pessimistic: $59.02. Optimistic: $63.83


Haemonetics Stock Prediction for Nov 2022

An uptrend is forecast for this month with an optimal target price of $62.844. Pessimistic: $59.45. Optimistic: $66.74


Haemonetics Stock Prediction for Dec 2022

An uptrend is forecast for this month with an optimal target price of $66.7403. Pessimistic: $62.67. Optimistic: $71.68




Haemonetics (HAE) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Jan 68.94 65.56 70.32 6.76
Feb 70.11 67.03 74.32 9.81
Mar 64.79 62.91 69.90 10.01
Apr 59.73 55.85 63.26 11.71
May 54.54 51.97 57.48 9.58
Jun 54.54 51.05 57.70 11.53
Jul 58.30 54.04 59.87 9.74
Aug 63.43 61.21 68.50 10.65
Sep 62.35 59.30 64.66 8.29
Oct 68.46 64.90 72.30 10.23
Nov 67.91 63.77 72.46 12.00
Dec 66.35 61.91 71.33 13.21

Haemonetics (HAE) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 60.91 56.59 65.48 13.58
Feb 55.06 52.26 58.20 10.22
Mar 56.94 54.49 61.15 10.89
Apr 51.36 49.10 54.49 9.90
May 49.20 46.44 50.92 8.79
Jun 47.18 44.54 50.67 12.10
Jul 45.29 43.85 48.06 8.77
Aug 48.01 46.43 50.94 8.86
Sep 48.35 46.17 49.36 6.46
Oct 43.76 40.56 46.60 12.96
Nov 43.23 39.77 44.57 10.77
Dec 44.44 43.37 47.73 9.12



Haemonetics (HAE) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 46.31 45.01 48.90 7.95
Feb 46.54 45.14 48.12 6.19
Mar 49.28 46.97 52.83 11.10
Apr 49.78 47.94 51.77 7.40
May 50.87 49.50 52.25 5.26
Jun 48.38 45.72 50.65 9.74
Jul 46.35 44.26 49.64 10.83
Aug 48.06 46.62 49.17 5.18
Sep 47.10 45.88 50.02 8.29
Oct 43.29 41.08 44.28 7.23
Nov 41.81 39.60 44.62 11.25
Dec 41.86 38.80 44.03 11.88

Haemonetics (HAE) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 40.10 38.98 42.54 8.39
Feb 39.54 37.92 42.42 10.62
Mar 42.74 40.13 44.92 10.66
Apr 43.94 42.79 47.41 9.73
May 43.28 42.37 45.48 6.85
Jun 44.62 43.50 46.40 6.25
Jul 43.50 41.81 44.55 6.15
Aug 42.11 40.05 43.88 8.73
Sep 41.14 40.28 43.16 6.67
Oct 43.16 40.35 45.66 11.63
Nov 43.42 41.55 46.89 11.39
Dec 41.68 38.80 44.93 13.64

Haemonetics information and performance

Haemonetics Corporation is a medical company offering hematology products and solutions. It operates through three segments: Plasma, Blood Center and Hospital. The company offers automated plasma collection devices, related disposable products and software, including NexSys PCS and PCS2 plasmapheresis equipment, as well as related disposable and intravenous solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations and supply chain; and the NexLynk DMS Donor Management System.

Haemonetics Address

125 SUMMER STREET, BOSTON, MA, US

Market Capitalization: 2 944 028 000 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: 204 288 000 $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: 133.33

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: 2.151

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: 0.432

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: -0.274

Quarterly Revenue Growth YOY: 0.081

Trailing PE: 133.33

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 18.62

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 3.199

Enterprise Value (EV) /Revenue

EV To EBITDA: 17.8

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 51112000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A

Percent Insiders: N/A

Percent Institutions: N/A




Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.